1. Introduction {#sec1-molecules-21-00176}
===============

Mogrosides are a group of cucurbitane-type triterpenoid saponins which have the common aglycone of mogrol \[[@B1-molecules-21-00176]\]. They are responsible for the sweet taste and bioactivities of Siraitiae Fructus (Luo Han Guo in Chinese, the ripe fruits of *Siraitia grosvenorii*), a traditional Chinese medicine and an edible fruit \[[@B2-molecules-21-00176]\].

Siamenoside I is one of the mogrosides, which is firstly isolated from *Siraitia siamensis* (a Chinese folk medicine) \[[@B3-molecules-21-00176]\] and then from *Siraitia grosvenorii* \[[@B4-molecules-21-00176]\]. Its relative sweetness (0.01% solution) to 5% sucrose is determined to be 563, higher than the famous sweetener mogroside V, making it the sweetest cucurbitane glycoside \[[@B4-molecules-21-00176]\].

Besides its intense sweet taste, siamenoside I also has several kinds of bioactivities. It can inhibit the induction of Epstein--Barr virus early antigen (EBV-EA) by 12-*O*-tetradecanoylphorbol-13-acetate (TPA) in Raji cells, which implies that it is a potential cancer chemopreventive agent \[[@B5-molecules-21-00176]\]. It also inhibits two-stage carcinogenesis induced by 9,10-dimethyl-1,2-benzanthracene (DMBA) and TPA in mice \[[@B6-molecules-21-00176]\]. Furthermore, it exhibits a maltase inhibitory effect with IC~50~ value of 10 mM, which is more potent than those of mogroside V and mogroside IV (IC~50~ of 14 mM and 12 mM, respectively) \[[@B7-molecules-21-00176]\].

In order to clarify the action mechanisms of the beneficial effects of mogrosides and to develop them into new health foods or drugs or sweeteners, it is necessary to investigate their metabolism and disposition. Up to now, there are only three reports on the metabolism of mogrosides. The first is about the human intestinal microflora biotransformation of mogroside III \[[@B8-molecules-21-00176]\]; the second is on the *in vivo* digestion, absorption and metabolism of 72% mogroside V in rats \[[@B9-molecules-21-00176]\], and the third is our study on the *in vitro*, *in vivo* metabolism of mogroside V (purity \>98%) and the distributions of its metabolites in rats \[[@B10-molecules-21-00176]\]. We find that mogroside V can be metabolized to its secondary glycosides and the aglycone morgol, and then morgol is oxidized to lots of metabolites. However, there are no reports on the metabolism of siamenoside I so far.

Although the importance of studying drug distribution in various organs is well established in the drug development field, the studies on the distributions of metabolites of bioactive natural products are neglected. Since our previous research indicates that the metabolites of natural products distribute unevenly in different organs of rats, such as mogroside V \[[@B10-molecules-21-00176]\] and (+)-catechin \[[@B11-molecules-21-00176]\], we believe that revealing the distributions of a bioactive natural product and its metabolites can be helpful in understanding its target organ and organ-specific bioactivities.

Accordingly, in the present work, the metabolites of siamenoside I and the distributions of siamenoside I and its metabolites in rats were firstly investigated by high-performance liquid chromatography-electrospray ionization-ion trap-time of flight-multistage mass spectrometry (HPLC-ESI-IT-TOF-MS^n^). In total, 86 new metabolites of siamenoside I in rats were detected and identified or tentatively identified, and the metabolic pathways and *in vivo* processes of siamenoside I were proposed. Siamenoside I and its metabolites were mainly distributed to intestine, stomach, kidney, and brain, and mogroside IIIE was the most widely distributed metabolite.

2. Results {#sec2-molecules-21-00176}
==========

2.1. Profiling the Metabolites of Siamenoside I in Different Biosamples by HPLC-ESI-IT-TOF-MS^n^ {#sec2dot1-molecules-21-00176}
------------------------------------------------------------------------------------------------

Based on the strategy described in [Section 4.7](#sec4dot7-molecules-21-00176){ref-type="sec"}, 86 new metabolites (**M1**--**M86**) of siamenoside I were detected altogether in different drug-containing samples by the HPLC-ESI-IT-TOF-MS^n^ technique ([Table 1](#molecules-21-00176-t001){ref-type="table"}, [Table S1](#app1-molecules-21-00176){ref-type="app"}, [Figure 1](#molecules-21-00176-f001){ref-type="fig"}, and [Figures S1--S25](#app1-molecules-21-00176){ref-type="app"}).

Eighty-three metabolites were detected in drug-containing feces; 19 metabolites were found in urine, and only two were detected in plasma.

As for different organs, 2, 7, 7, 3, 13, 21, 19, and 14 metabolites were detected in heart, liver, spleen, lungs, kidneys, stomach, intestine, and brain, respectively. Furthermore, no metabolites were detected in muscles.

2.2. Identification of the Metabolites of Siamenoside I in Different Biosamples by HPLC-ESI-IT-TOF-MS^n^ {#sec2dot2-molecules-21-00176}
--------------------------------------------------------------------------------------------------------

Nine new metabolites of siamenoside I were unambiguously identified to be mogroside IVA (**M3**), mogroside IVE (**M4**), mogroside III (**M8**), mogroside IIIE (**M9**), mogroside IIIA~1~ (**M10**), mogroside IIE (**M15**), mogroside IIA~2~ (**M17**), 11-oxomogroside IIE (**M20**), and mogrol (**M29**) sequentially by comparison of their LC-MS^n^ data to those of reference compounds.

The other 77 metabolites were tentatively identified by interpretation of their LC-MS^n^ data and by comparison with literature.

These 86 new metabolites of siamenoside I can be classified into 24 classes according to their formative reactions and molecular formulae.

molecules-21-00176-t001_Table 1

###### 

LC-MS data of siamenoside I and its 86 metabolites formed in rats and their formative reactions.

  No.           t~R~ (min)   Meas. (Da)   Pred.(Da)   Err. (ppm)   DBE ^2^   Formula            Identification                                    Reactions
  ------------- ------------ ------------ ----------- ------------ --------- ------------------ ------------------------------------------------- -----------------
  **M0 ^1^**    24.966       1169.5959    1169.5961   0.17         9         C~54~H~92~O~24~    siamenoside I                                     −
  **M1**        25.698       1285.6444    1285.6434   0.78         10        C~60~H~102~O~29~   mogroside V isomer                                +Glc
  **M2**        26.043       1285.6441    1285.6434   0.54         10        C~60~H~102~O~29~   mogroside V isomer                                +Glc
  **M3 ^1^**    25.345       1169.5905    1169.5961   −0.09        9         C~54~H~92~O~24~    mogroside IVA                                     isomerization
  **M4 ^1^**    25.960       1169.5923    1169.5961   −3.25        9         C~54~H~92~O~24~    mogroside IVE                                     isomerization
  **M5**        26.696       1169.5950    1169.5961   −0.94        9         C~54~H~92~O~24~    mogroside IV isomer                               isomerization
  **M6**        25.923       1167.5730    1167.5804   −2.23        10        C~54~H~90~O~24~    dehydrogenated siamenoside I                      −2H
  **M7**        25.983       1153.5957    1153.6011   −4.25        9         C~54~H~92~O~23~    deoxygenated siamenoside I                        −O
  **M8 ^1^**    26.803       1007.5425    1007.5432   −0.69        8         C~48~H~82~O~19~    mogroside III                                     −Glc
  **M9 ^1^**    27.173       1007.5387    1007.5432   −4.47        8         C~48~H~82~O~19~    mogroside IIIE                                    −Glc
  **M10 ^1^**   30.217       1007.5376    1007.5432   −5.56        8         C~48~H~82~O~19~    mogroside IIIA~1~                                 −Glc
  **M11**       30.525       1007.5395    1007.5432   −3.67        8         C~48~H~82~O~19~    mogroside III isomer                              −Glc
  **M12**       30.940       1007.5385    1007.5432   −4.66        8         C~48~H~82~O~19~    mogroside III isomer                              −Glc
  **M13**       26.927       1005.5269    1005.5276   0.70         9         C~48~H~80~O~19~    dehydrogenated mogroside III isomer               −Glc − 2H
  **M14**       27.728       991.5441     991.5483    −4.24        8         C~48~H~82~O~18~    deoxygenated mogroside III isomer                 −Glc − O
  **M15 ^1^**   29.365       845.4881     845.4904    −2.72        7         C~42~H~72~O~14~    mogroside IIE                                     −2Glc
  **M16**       30.648       845.4944     845.4904    4.73         7         C~42~H~72~O~14~    mogroside II isomer                               −2Glc
  **M17 ^1^**   31.775       845.4910     845.4904    0.71         7         C~42~H~72~O~14~    mogroside IIA~2~                                  −2Glc
  **M18**       33.298       845.4884     845.4904    −2.37        7         C~42~H~72~O~14~    mogroside II isomer                               −2Glc
  **M19**       33.905       845.4918     845.4904    1.66         7         C~42~H~72~O~14~    mogroside II isomer                               −2Glc
  **M20 ^1^**   29.908       843.4737     843.4748    −1.30        8         C~42~H~70~O~14~    11-oxomogroside IIE                               −2Glc − 2H
  **M21**       33.604       843.4726     843.4748    −2.61        8         C~42~H~70~O~14~    dehydrogenated mogroside II isomer                −2Glc − 2H
  **M22**       34.028       829.4946     829.4955    −1.08        7         C~42~H~72~O~13~    deoxygenated mogroside II isomer                  −2Glc − O
  **M23**       34.813       827.4780     827.4798    −2.18        8         C~42~H~70~O~13~    dehydrogenated deoxygenated mogroside II isomer   −2Glc − 2H − O
  **M24**       34.997       683.4348     683.4376    −1.76        6         C~36~H~62~O~9~     mogroside IA~1~                                   −3Glc
  **M25**       37.507       683.4366     683.4376    1.46         6         C~36~H~62~O~9~     mogroside IE~1~                                   −3Glc
  **M26**       36.120       681.4196     681.4219    −3.38        7         C~36~H~60~O~9~     dehydrogenated mogroside I isomer                 −3Glc − 2H
  **M27**       38.860       681.4215     681.4219    −0.59        7         C~36~H~60~O~9~     dehydrogenated mogroside I isomer                 −3Glc − 2H
  **M28**       45.978       521.3834     521.3848    −2.69        5         C~30~H~52~O~4~     mogrol isomer                                     −4Glc
  **M29 ^1^**   46.467       521.3838     521.3848    −1.92        5         C~30~H~52~O~4~     mogrol                                            −4Glc
  **M30**       52.478       519.3676     519.3691    −2.89        6         C~30~H~50~O~4~     dehydrogenated mogrol                             −4Glc − 2H
  **M31**       52.953       519.3687     519.3691    −0.77        6         C~30~H~50~O~4~     dehydrogenated mogrol                             −4Glc − 2H
  **M32**       23.007       553.3721     553.3746    −4.52        5         C~30~H~52~O~6~     dihydroxylated mogrol                             −4Glc + 2O
  **M33**       26.528       553.3699     553.3746    −8.49        5         C~30~H~52~O~6~     dihydroxylated mogrol                             −4Glc + 2O
  **M34**       27.482       553.3717     553.3746    −5.24        5         C~30~H~52~O~6~     dihydroxylated mogrol                             −4Glc + 2O
  **M35**       28.152       553.3740     553.3746    −1.08        5         C~30~H~52~O~6~     dihydroxylated mogrol                             −4Glc + 2O
  **M36**       26.475       551.3559     551.3589    −5.40        6         C~30~H~50~O~6~     dehydrogenated dihydroxylated mogrol              −4Glc − 2H + 2O
  **M37**       27.050       551.3557     551.3589    −5.80        6         C~30~H~50~O~6~     dehydrogenated dihydroxylated mogrol              −4Glc − 2H + 2O
  **M38**       29.487       551.3566     551.3589    −4.17        6         C~30~H~50~O~6~     dehydrogenated dihydroxylated mogrol              −4Glc − 2H + 2O
  **M39**       30.887       551.3558     551.3589    −5.62        6         C~30~H~50~O~6~     dehydrogenated dihydroxylated mogrol              −4Glc − 2H + 2O
  **M40**       31.537       551.3561     551.3589    −5.04        6         C~30~H~50~O~6~     dehydrogenated dihydroxylated mogrol              −4Glc − 2H + 2O
  **M41**       33.122       551.3549     551.3589    −7.25        6         C~30~H~50~O~6~     dehydrogenated dihydroxylated mogrol              −4Glc − 2H + 2O
  **M42**       16.305       569.3655     569.3695    −7.03        5         C~30~H~52~O~7~     trihydroxylated mogrol                            −4Glc + 3O
  **M43**       16.728       569.3671     569.3695    −4.22        5         C~30~H~52~O~7~     trihydroxylated mogrol                            −4Glc + 3O
  **M44**       17.280       569.3660     569.3695    −6.15        5         C~30~H~52~O~7~     trihydroxylated mogrol                            −4Glc + 3O
  **M45**       18.140       569.3674     569.3695    −3.69        5         C~30~H~52~O~7~     trihydroxylated mogrol                            −4Glc + 3O
  **M46**       18.923       569.3675     569.3695    −3.51        5         C~30~H~52~O~7~     trihydroxylated mogrol                            −4Glc + 3O
  **M47**       21.464       569.3675     569.3695    −3.51        5         C~30~H~52~O~7~     trihydroxylated mogrol                            −4Glc + 3O
  **M48**       21.755       569.3674     569.3695    −3.69        5         C~30~H~52~O~7~     trihydroxylated mogrol                            −4Glc + 3O
  **M49**       22.121       569.3666     569.3695    −5.09        5         C~30~H~52~O~7~     trihydroxylated mogrol                            −4Glc + 3O
  **M50**       22.531       569.3667     569.3695    −7.03        5         C~30~H~52~O~7~     trihydroxylated mogrol                            −4Glc + 3O
  **M51**       11.410       567.3489     567.3539    −8.80        6         C~30~H~50~O~7~     dehydrogenated trihydroxylated mogrol             −4Glc − 2H + 3O
  **M52**       18.482       567.3463     567.3539    −13.4        6         C~30~H~50~O~7~     dehydrogenated trihydroxylated mogrol             −4Glc − 2H + 3O
  **M53**       19.893       567.3534     567.3539    −2.64        6         C~30~H~50~O~7~     dehydrogenated trihydroxylated mogrol             −4Glc − 2H + 3O
  **M54**       20.977       567.3494     567.3539    −0.88        6         C~30~H~50~O~7~     dehydrogenated trihydroxylated mogrol             −4Glc − 2H + 3O
  **M55**       21.761       567.3512     567.3539    −7.93        6         C~30~H~50~O~7~     dehydrogenated trihydroxylated mogrol             −4Glc − 2H + 3O
  **M56**       22.365       567.3507     567.3539    −4.76        6         C~30~H~50~O~7~     dehydrogenated trihydroxylated mogrol             −4Glc − 2H + 3O
  **M57**       24.123       567.3497     567.3539    −5.64        6         C~30~H~50~O~7~     dehydrogenated trihydroxylated mogrol             −4Glc − 2H + 3O
  **M58**       24.478       567.3508     567.3539    −7.23        6         C~30~H~50~O~7~     dehydrogenated trihydroxylated mogrol             −4Glc − 2H + 3O
  **M59**       25.380       567.3499     567.3539    −5.46        6         C~30~H~50~O~7~     dehydrogenated trihydroxylated mogrol             −4Glc − 2H + 3O
  **M60**       27.050       567.3498     567.3539    −7.05        6         C~30~H~50~O~7~     dehydrogenated trihydroxylated mogrol             −4Glc − 2H + 3O
  **M61**       27.728       567.3520     567.3539    −7.23        6         C~30~H~50~O~7~     dehydrogenated trihydroxylated mogrol             −4Glc − 2H + 3O
  **M62**       24.412       565.3351     565.3382    −5.48        7         C~30~H~48~O~7~     didehydrogenated trihydroxylated mogrol           −4Glc − 4H + 3O
  **M63**       26.052       565.3357     565.3382    −4.42        7         C~30~H~48~O~7~     didehydrogenated trihydroxylated mogrol           −4Glc − 4H + 3O
  **M64**       28.810       565.3368     565.3382    −2.48        7         C~30~H~48~O~7~     didehydrogenated trihydroxylated mogrol           −4Glc − 4H + 3O
  **M65**       30.340       565.3347     565.3382    −6.19        7         C~30~H~48~O~7~     didehydrogenated trihydroxylated mogrol           −4Glc − 4H + 3O
  **M66**       13.872       585.3613     585.3644    −5.30        5         C~30~H~52~O~8~     tetrahydroxylated mogrol                          −4Glc + 4O
  **M67**       14.242       585.3601     585.3644    −7.35        5         C~30~H~52~O~8~     tetrahydroxylated mogrol                          −4Glc + 4O
  **M68**       14.603       585.3608     585.3644    −6.15        5         C~30~H~52~O~8~     tetrahydroxylated mogrol                          −4Glc + 4O
  **M69**       18.307       585.3603     585.3644    −4.95        5         C~30~H~52~O~8~     tetrahydroxylated mogrol                          −4Glc + 4O
  **M70**       19.408       585.3613     585.3644    −5.30        5         C~30~H~52~O~8~     tetrahydroxylated mogrol                          −4Glc + 4O
  **M71**       15.573       583.3444     583.3488    −7.54        6         C~30~H~50~O~8~     dehydrogenated tetrahydroxylated mogrol           −4Glc − 2H + 4O
  **M72**       15.997       583.3454     583.3488    −8.54        6         C~30~H~50~O~8~     dehydrogenated tetrahydroxylated mogrol           −4Glc − 2H + 4O
  **M73**       20.492       583.3454     583.3488    −6.00        6         C~30~H~50~O~8~     dehydrogenated tetrahydroxylated mogrol           −4Glc − 2H + 4O
  **M74**       20.800       583.3465     583.3488    −3.94        6         C~30~H~50~O~8~     dehydrogenated tetrahydroxylated mogrol           −4Glc − 2H + 4O
  **M75**       21.453       583.3465     583.3488    −3.94        6         C~30~H~50~O~8~     dehydrogenated tetrahydroxylated mogrol           −4Glc − 2H + 4O
  **M76**       22.895       583.3452     583.3488    −6.17        6         C~30~H~50~O~8~     dehydrogenated tetrahydroxylated mogrol           −4Glc − 2H + 4O
  **M77**       24.710       583.3447     583.3488    −7.03        6         C~30~H~50~O~8~     dehydrogenated tetrahydroxylated mogrol           −4Glc − 2H + 4O
  **M78**       20.615       581.3297     581.3331    −5.85        7         C~30~H~48~O~8~     didehydrogenated tetrahydroxylated mogrol         −4Glc − 4H + 4O
  **M79**       21.815       581.3290     581.3331    −7.05        7         C~30~H~48~O~8~     didehydrogenated tetrahydroxylated mogrol         −4Glc − 4H + 4O
  **M80**       23.007       581.3292     581.3331    −6.71        7         C~30~H~48~O~8~     didehydrogenated tetrahydroxylated mogrol         −4Glc − 4H + 4O
  **M81**       23.433       581.3306     581.3331    −4.03        7         C~30~H~48~O~8~     didehydrogenated tetrahydroxylated mogrol         −4Glc − 4H + 4O
  **M82**       23.988       581.3308     581.3331    −3.96        7         C~30~H~48~O~8~     didehydrogenated tetrahydroxylated mogrol         −4Glc − 4H + 4O
  **M83**       25.682       581.3304     581.3331    −4.64        7         C~30~H~48~O~8~     didehydrogenated tetrahydroxylated mogrol         −4Glc − 4H + 4O
  **M84**       25.990       581.3291     581.3331    −4.00        7         C~30~H~48~O~8~     didehydrogenated tetrahydroxylated mogrol         −4Glc − 4H + 4O
  **M85**       17.707       587.2977     587.2992    −2.55        7         C~30~H~48~O~9~     didehydrogenated pentahydroxylated mogrol         −4Glc − 4H + 5O
  **M86**       18.607       587.2983     587.2992    −1.53        7         C~30~H~48~O~9~     didehydrogenated pentahydroxylated mogrol         −4Glc − 4H + 5O

^1^ Confirmed by comparison with reference compounds. ^2^ DBE, double bond equivalent.

### 2.2.1. Metabolites Formed by Monoglycosylation (**M1**, **M2**) {#sec2dot2dot1-molecules-21-00176}

**M1**--**M2** showed \[M + HCOOH − H\]^−^ at *m*/*z* 1285.64, which indicated that their molecular formulae were C~60~H~102~O~29~. The formulae had an additional glucosyl (C~6~H~10~O~5~) than that of siamenoside I (C~54~H~92~O~24~). Hence, they were mogroside V isomers.

![The proposed metabolic pathways of siamenoside I in rats.](molecules-21-00176-g001){#molecules-21-00176-f001}

### 2.2.2. Metabolites Formed by Isomerization (**M3**--**M5**) {#sec2dot2dot2-molecules-21-00176}

**M3**--**M5** showed \[M + HCOOH − H\]^−^ at *m*/*z* 1169.59, indicating the molecular formula of C~54~H~92~O~24~, which was the same to siamenoside I. Hence, they were mogroside IV isomers, and **M3**--**M4** were further confirmed as mogroside IVA and mogroside IVE by comparison with reference compounds.

### 2.2.3. Metabolites Formed by Dehydrogenation (**M6**) {#sec2dot2dot3-molecules-21-00176}

The molecular formula of **M6** was predicted to be C~54~H~90~O~24~ based on its \[M + HCOOH − H\]^−^ at *m*/*z* 1167.5730, which was formed by loss of two hydrogen atoms from siamenoside I, thus **M6** was tentatively identified as dehydrogenated siamenoside I.

### 2.2.4. Metabolites Formed by Deoxygenation (**M7**) {#sec2dot2dot4-molecules-21-00176}

The molecular formula of **M7** was C~54~H~92~O~23~ calculated from its \[M + HCOOH − H\]^−^ at *m*/*z* 1153.5957, which has one less oxygen atom than that of siamenoside I. Accordingly, it was tentatively identified as deoxygenated siamenoside I.

### 2.2.5. Metabolites Formed by Deglucosylation (**M8**--**M12**) {#sec2dot2dot5-molecules-21-00176}

**M8**--**M12** showed \[M + HCOOH − H\]^−^ at *m*/*z* 1007.54, implying their molecular formulae of C~48~H~82~O~19~. The formulae had one less glucosyl group (element composition: C~6~H~10~O~5~) than that of siamenoside I, so they were mogroside III isomers. In addition, **M8**--**M10** were unambiguously identified as mogroside III, mogroside IIIE, and mogroside IIIA~1~ by comparison with reference compounds.

### 2.2.6. Metabolites Formed by Deglucosylation and Dehydrogenation (**M13**) {#sec2dot2dot6-molecules-21-00176}

**M13** had the molecular formula of C~48~H~80~O~19~ predicted by its \[M + HCOOH − H\]^−^ at *m*/*z* 1005.5269. Compared with C~48~H~82~O~19~ of mogroside III isomers, it was tentatively identified as dehydrogenated mogroside III isomer. Moreover, in the MS^2^ of **M13**, \[M − H − 2Glc\]^−^ at *m*/*z* 797.4629 (C~42~H~69~O~14~), \[M −H − 3Glc\]^−^ at *m*/*z* 635.4090 (C~36~H~59~O~9~), \[aglycon − H\]^−^ at *m*/*z* 473.3623 (C~30~H~49~O~4~) were observed. Hence, **M13** was a triglucoside of dehydrogenated mogrol.

### 2.2.7. Metabolites Formed by Deglucosylation and Deoxygenation (**M14**) {#sec2dot2dot7-molecules-21-00176}

The molecular formula of **M14** was calculated to be C~48~H~82~O~18~ by its \[M + HCOOH − H\]^−^ at *m*/*z* 991.5441, which had one less oxygen atom than C~48~H~82~O~19~ of mogroside III, so it was tentatively identified as deoxygenated mogroside III isomer.

### 2.2.8. Metabolites Formed By Dideglucosylation (**M15**--**M19**) {#sec2dot2dot8-molecules-21-00176}

The molecular formulae of **M15**--**M19** were determined to be C~42~H~72~O~14~ based on their \[M + HCOOH − H\]^−^ at *m*/*z* 845.49, which had one less glucosyl group (element composition: C~6~H~10~O~5~) than C~48~H~82~O~19~ of mogroside III, so they were mogroside II isomers. Furthermore, **M15** and **M17** were confirmed to be mogroside IIE and mogroside IIA~2~ by comparison with reference compounds.

### 2.2.9. Metabolites Formed by Dideglucosylation and Dehydrogenation (**M20**--**M21**) {#sec2dot2dot9-molecules-21-00176}

**M20**--**M21** showed \[M + HCOOH − H\]^−^ at *m*/*z* 843.47 in MS, suggesting their molecular formulae of C~42~H~70~O~14~. Additionally, they showed \[aglycon − H\]^−^ at *m*/*z* 473.3623 (C~30~H~49~O~4~) in MS^2^ spectra. Therefore, they were tentatively identified as dehydrogenated mogroside II isomer, *i.e.*, diglucoside of dehydrogenated mogrol. Further, **M20** was unambiguously identified as 11-oxomogroside IIE by comparison with reference compounds.

### 2.2.10. Metabolites Formed by Dideglucosylation and Deoxygenation (**M22**) {#sec2dot2dot10-molecules-21-00176}

**M22** was tentatively identified as deoxygenated mogroside II isomer, since its molecular formula was determined to be C~42~H~72~O~13~ by its \[M + HCOOH − H\]^−^ at *m*/*z* 829.4946, which had one less oxygen atom than C~42~H~72~O~14~ of mogroside II isomers. In addition, **M22** showed \[M − H\]^−^ at *m*/*z* 783.4833 (C~42~H~71~O~13~), \[M−H−C~6~H~10~O~4~ (deoxyhexosyl)\]^−^ at *m*/*z* 637.4252 (C~36~H~61~O~9~), and \[M−H−C~6~H~10~O~4~−Glc\]^−^ at *m*/*z* 475.3742 (C~30~H~51~O~4~) in MS^2^ spectra, which indicated that the deoxygenation occurred in hexose and the aglycone was mogrol. Thus, **M22** was identified as a deoxyhexosyl-glucosyl mogrol.

### 2.2.11. Metabolites Formed by Dideglucosylation, Dehydrogenation, and Deoxygenation (**M23**) {#sec2dot2dot11-molecules-21-00176}

The molecular formula of **M23** was determined to be C~42~H~70~O~13~ according to its \[M + HCOOH − H\]^−^ at *m*/*z* 827.4780, which lost two hydrogen atoms from C~42~H~72~O~13~ of **M22**. Consequently, **M23** was tentatively identified as a dehydrogenated deoxygenated mogroside II isomer.

### 2.2.12. Metabolites Formed by Trideglucosylation (**M24**--**M25**) {#sec2dot2dot12-molecules-21-00176}

**M24**--**M25** showed \[M + HCOOH − H\]^−^ at *m*/*z* 683.43 in MS, and \[M−H\]^−^ at *m*/*z* 637.42 (C~36~H~61~O~9~), \[aglycone−H\]^−^ at *m*/*z* 475.37 (C~30~H~51~O~4~) in MS^2^ spectra, which implied that they were mogrol glucoside. By comparison with the LC-MS^n^ data in literature \[[@B10-molecules-21-00176]\], **M24** and **M25** were tentatively identified as mogroside IA~1~ and mogroside IE~1~, respectively.

### 2.2.13. Metabolites Formed by Trideglucosylation and Dehydrogenation (**M26**--**M27**) {#sec2dot2dot13-molecules-21-00176}

The molecular formulae of **M26**--**M27** were predicted to be C~36~H~60~O~9~ based on its \[M + HCOOH − H\]^−^ at *m*/*z* 681.42 in MS, which had two less hydrogen atoms than C~36~H~62~O~9~ of mogroside I isomers. In their negative ion (NI) MS^2^ spectra, \[M − H\]^−^ at *m*/*z* 635.41 (C~36~H~59~O~9~) and \[aglycone−H\]^−^ at *m*/*z* 473.36 (C~30~H~49~O~4~) were detected. As a result, **M26**--**M27** were tentatively identified as glucosides of dehydrogenated mogrol, *i.e.*, dehydrogenated mogroside I isomers.

### 2.2.14. Metabolites Formed by Tetradeglucosylation (**M28**--**M29**) {#sec2dot2dot14-molecules-21-00176}

**M29** was unambiguously identified as mogrol by comparison with reference compound. **M28** had the same molecular formula to mogrol, which showed \[M + HCOOH − H\]^−^ at *m*/*z* 521.38 in MS, so it was a mogrol isomer.

### 2.2.15. Metabolites Formed by Tetradeglucosylation and Dehydrogenation (**M30**--**M31**) {#sec2dot2dot15-molecules-21-00176}

**M30** and **M31** had the molecular formulae of C~30~H~50~O~4~ predicted by their \[M + HCOOH − H\]^−^ at *m*/*z* 519.36, which had two less hydrogen atoms than C~30~H~52~O~4~ of mogrol, thus they were tentatively identified as dehydrogenated mogrols.

### 2.2.16. Metabolites Formed by Tetradeglucosylation and Dihydroxylation (**M32**--**M35**) {#sec2dot2dot16-molecules-21-00176}

**M32**--**M35** showed \[M + HCOOH − H\]^−^ at *m*/*z* 553.37, indicating the molecular formula of C~30~H~52~O~6~. Compared to C~30~H~52~O~4~ of mogrol, it had two more oxygen atoms. Accordingly, **M32**--**M35** were tentatively identified as dihydroxylated mogrols.

In addition, the possible hydroxylation sites of **M32** can be deduced by its MS^2^ data and one possible structure of **M32** is shown in [Figure 2](#molecules-21-00176-f002){ref-type="fig"}a. The nomenclature for the fragmentation pathways and fragment ions of cucurbitanes proposed by the authors \[[@B10-molecules-21-00176]\] were used in this study.

In MS^2^ spectra of **M32**, *m*/*z* 433.3011 (\[^c,j^ABCDE − H\]^−^, C~27~H~45~O~4~) generated by ^c,j^A cleavage and *m*/*z* 349.2406 (\[^s,t^DE − H\]^−^, C~21~H~33~O~4~) generated by ^s,t^D cleavage were observed, which indicated that one hydroxylation site was in ^c,j^A, and the other was in ^c,j^ABC^s,t^D ([Figure 2](#molecules-21-00176-f002){ref-type="fig"}a).

![The MS^2^ spectra, characteristic fragment ions, and proposed fragmentation pathways of **M32** and **M53**. (**a**) **M32**; (**b**) **M53**.](molecules-21-00176-g002){#molecules-21-00176-f002}

### 2.2.17. Metabolites Formed by Tetradeglucosylation, Dihydroxylation, and Dehydrogenation (**M36**--**M41**) {#sec2dot2dot17-molecules-21-00176}

The molecular formulae of **M36**--**M41** were calculated to be C~30~H~50~O~6~ based on their \[M + HCOOH − H\]^−^ at *m*/*z* 551.35. Compared to C~30~H~52~O~6~ of **M32**--**M35**, it had two less hydrogen atoms. Accordingly, **M36**--**M41** were tentatively identified as dehydrogenated dihydroxylated mogrols.

### 2.2.18. Metabolites Formed by Tetradeglucosylation and Trihydroxylation (**M42**--**M50**) {#sec2dot2dot18-molecules-21-00176}

**M42**--**M50** had the molecular formulae of C~30~H~52~O~7~ predicted by their \[M + HCOOH − H\]^−^ at *m*/*z* 569.36. Compared to C~30~H~52~O~6~ of **M32**--**M35** (dihydroxylated mogrol), it had one more oxygen atom. Accordingly, **M42**--**M50** were tentatively identified as trihydroxylated mogrols.

### 2.2.19. Metabolites Formed by Tetradeglucosylation, Trihydroxylation, and Dehydrogenation (**M51**--**M61**) {#sec2dot2dot19-molecules-21-00176}

The molecular formulae of **M51**--**M61** were determined to be C~30~H~50~O~7~ on the basis of their \[M + HCOOH − H\]^−^ at *m*/*z* 567.35. In comparison with C~30~H~52~O~7~ of **M42**--**M50** (trihydroxylated mogrol), it had two less hydrogen atoms. As a result, **M51**--**M61** were tentatively identified as dehydrogenated trihydroxylated mogrols.

Further, the possible hydroxylation sites of **M53** could be deduced by its MS^2^ data, and one possible structure of **M53** is shown in [Figure 2](#molecules-21-00176-f002){ref-type="fig"}b.

**M53** showed \[M + HCOOH − H\]^−^ at *m*/*z* 567.3524 in MS, and then it was fragmented into \[M − H\]^−^ at *m*/*z* 521.3207 (C~30~H~49~O~7~) in MS^2^ spectrum. The \[M − H\]^−^ was further cleaved into product ions at *m*/*z* 503.3364 (C~30~H~47~O~6~), 485.3261 (C~30~H~45~O~5~), and 467.3056 (C~30~H~43~O~4~) formed by sequential losses of H~2~O. It was also cleaved into product ion at *m*/*z* 415.2911 (C~26~H~39~O~4~) by losing C~4~H~10~O~3~ (^x^E+H), which indicated that one hydroxylation site was in ^x^E. Besides, the characteristic fragment ions at *m*/*z* 397.2713 (C~26~H~37~O~3~), *m*/*z* 379.2621 (C~26~H~35~O~2~), *m*/*z* 355.2613 (C~24~H~35~O~2~), and *m*/*z* 325.2449 (C~22~H~29~O~2~) were observed in MS^2^, indicating that the other two hydroxylation sites should be located at ^a,c^ABCD^u^E ([Figure 2](#molecules-21-00176-f002){ref-type="fig"}b).

### 2.2.20. Metabolites Formed by Tetradeglucosylation, Trihydroxylation, and Didehydrogenation (**M62**--**M65**) {#sec2dot2dot20-molecules-21-00176}

**M62**-**M65** had the molecular formulae of C~30~H~48~O~7~ predicted by their \[M + HCOOH − H\]^−^ at *m*/*z* 565.33, which had two less hydrogen atoms than C~30~H~50~O~7~ of **M51**--**M61**. Accordingly, **M62**--**M65** were tentatively identified as didehydrogenated trihydroxylated mogrols.

### 2.2.21. Metabolites Formed by Tetradeglucosylation and Tetrahydroxylation (**M66**--**M70**) {#sec2dot2dot21-molecules-21-00176}

**M66**--**M70** showed \[M + HCOOH − H\]^−^ at *m*/*z* 585.36, indicating the molecular formula of C~30~H~52~O~8~. Compared with C~30~H~52~O~4~ of mogrol, their molecular formula had four more oxygen atoms. Therefore, they were tetrahydroxylated mogrols.

### 2.2.22. Metabolites Formed by Tetradeglucosylation, Tetrahydroxylation, and Dehydrogenation (**M71**--**M77**) {#sec2dot2dot22-molecules-21-00176}

The molecular formulae of **M71**--**M77** were determined to be C~30~H~50~O~8~ based on their \[M + HCOOH − H\]^−^ at *m*/*z* 583.34, which had two less hydrogen atoms than C~30~H~52~O~8~ of **M66**--**M70** (tetrahydroxylated mogrol). Accordingly, they were tentatively identified as dehydrogenated tetrahydroxylated mogrol.

Besides, the possible dehydrogenation and hydroxylation sites of **M74** could be deduced by its MS^2^ and MS^3^ data, and one possible structure of **M74** is shown in [Figure 3](#molecules-21-00176-f003){ref-type="fig"}a.

The characteristic product ions at *m*/*z* 479.2977 (C~27~H~43~O~7~, ABCD^y^E^−^) produced by ^y^E cleavage, *m*/*z* 419.2762 (C~25~H~39~O~5~) generated by ^a,c^A cleavage, and *m*/*z* 195.1347 (C~12~H~19~O~2~) generated by ^n,p^C cleavage indicated that the C~24~-hydroxyl group of **M74** was dehydrogenated, and one of the four tetrahydroxylation sites was at C~2~, one was in ^n,p^CD^y^E, and the other two were in AB^n,p^C ([Figure 3](#molecules-21-00176-f003){ref-type="fig"}a).

![The MS^2^ spectra, characteristic fragment ions, and proposed fragmentation pathways of **M74** and **M85**. (**a**) **M74**; (**b**) **M85**.](molecules-21-00176-g003){#molecules-21-00176-f003}

### 2.2.23. Metabolites Formed by Tetradeglucosylation, Tetrahydroxylation, and Didehydrogenation (**M78**--**M84**) {#sec2dot2dot23-molecules-21-00176}

**M78**--**M84** showed \[M + HCOOH − H\]^−^ at *m*/*z* 581.33 in their MS, indicating their molecular formulae of C~30~H~48~O~8~, which had two less hydrogen atoms than C~30~H~50~O~8~ of **M71**--**M77**. Therefore, **M78**--**M84** were tentatively identified to be didehydrogenated tetrahydroxylated mogrol.

### 2.2.24. Metabolites Formed by Tetradeglucosylation, Pentahydroxylation, and Didehydrogenation (**M85**--**M86**) {#sec2dot2dot24-molecules-21-00176}

**M85**--**M86** had the molecular formulae of C~30~H~48~O~9~ predicted by their \[M + HCOOH − H\]^−^ at *m*/*z* 587.29 in their MS, which had one more oxygen atom than C~30~H~48~O~8~ of **M78**--**M84**. Accordingly, **M85**--**M86** were tentatively identified as didehydrogenated pentahydroxylated mogrol.

In addition, the possible dehydrogenation and hydroxylation sites of **M85** could be deduced by its MS^2^ and MS^3^ data, and one possible structure of **M85** is shown in [Figure 3](#molecules-21-00176-f003){ref-type="fig"}b.

**M85** showed \[M + Cl\]^−^ at *m*/*z* 587.2977, which was fragmented into \[M − H\]^−^ at *m*/*z* 551.3126 (C~30~H~47~O~9~) in MS^2^ spectrum. The \[M − H\]^−^ was then fragmented into characteristic product ions at *m*/*z* 433.2617 (C~25~H~37~O~6~, \[^a,d^ABCDE − 2H − H\]^−^) and *m*/*z* 417.2600 (C~25~H~37~O~5~, \[ABCD^w^E\]^−^) by ^a,d^A cleavage and ^w^E cleavage respectively, which implied that two of the five hydroxylation sites were in ^a,d^A, other two were in ^w^E. Furthermore, the ion at *m*/*z* 417.2600 (C~25~H~37~O~5~, \[ABCD^w^E\]^−^) was cleaved into product ions at *m*/*z* 399.2515 (C~25~H~35~O~4~) and *m*/*z* 203.0987 (C~13~H~15~O~2~) by sequential loss of H~2~O and ^l,p^CD^w^E (C~12~H~20~O~2~) in MS^3^ spectra, which indicated that the last of the five hydroxylation sites was in ^l,p^CD^w^E.

2.3. Distribution of the Metabolites of Siamenoside I in Rats {#sec2dot3-molecules-21-00176}
-------------------------------------------------------------

The peak areas and distributions of siamenoside I and the 86 identified metabolites in different biological samples are shown in [Table 2](#molecules-21-00176-t002){ref-type="table"}.

molecules-21-00176-t002_Table 2

###### 

Distribution of siamenoside I and its 86 metabolites in rat organs and their peak areas calculated from extracted ion chromatograms (EICs).

  No.                 Feces           Urine                   Plasma      Heart ^1^                Liver ^1^    Spleen ^1^               Lung ^1^    Kidney ^1^               Stomach ^1^   Intestine ^1^            Brain ^1^    Muscle      TPA ^2^
  ------------------- --------------- ----------------------- ----------- ------------------------ ------------ ------------------------ ----------- ------------------------ ------------- ------------------------ ------------ ----------- ---------------
  **M0**              9,489,561       45,194,235              929,711                                                                    655,725     1,151,491                15,473,808    1,201,5247               1,162,190                86,071,968
  **M1**              1,144,657       9,555,900                                                                                                                               2,001,769     1,487,067                680,786                  14,870,179
  **M2**                              15,997,951                                                                                                                                                                     531,345                  16,529,296
  **M3**              760,580         847,869                                                                                                        1,307,673                1,655,097     2,264,310                177,956                  7,013,485
  **M4**              545,593         5,114,666                                                    2,993,972    1,200,234                            2,991,375                1,454,847     2,022,516                66,665                   16,389,868
  **M5**              1,984,320       2,244,041                                                                                                                                             3,096,436                301,433                  7,626,230
  **M6**              1,370,701       24,868,935              522,375                                                                    216,179     460,499                  5,658,908     2,342,276                8,964,568                44,404,441
  **M7**              151,476         1,610,485                                                                                                                                                                                               1,761,961
  **M8**              686,710         509,105                                                                                                                                 9,795,285     3,463,191                                         14,454,291
  **M9**              5,499,380       4,564,759               247,245     3,396,211                10,439,099   1,349,085                621,654     17,082,221               23,756,273    15,351,670               7,796,211                90,103,808
  **M10**             25,071,251                                                                                                                                                                                                              25,071,251
  **M11**             6,584,321                                                                                                                                                                                                               6,584,321
  **M12**             7,864,503                                                                                                                                                                                                               7,864,503
  **M13**             5,673,582       927,152                                                      1,104,655    1,569,801                126,725     2,884,615                10,255,235                             861,731                  23,403,496
  **M14**             4,700,498                                                                                                                                               1,594,595     2,186,093                                         8,481,186
  **M15**             122,469,048     2,086,502                           752,082                               1,976,,058                                                    9,533,756     34,065,738                                        170,883,184
  **M16**             10,029,179                                                                                                                                                                                                              10,029,179
  **M17**             14,873,427                                                                                                                                              3,964,569                                                       18,837,996
  **M18**             131,377,697     2,775,395                                                                 2,221,834                            1,382,313                6,051,761                              868,285                  144,677,285
  **M19**             45,423,120      394,065                                                                                                                                               8,102,455                562,370                  54,482,010
  **M20**             50,669,383                                                                                447,658                                                       1,165,195     34,649,284                                        86,931,520
  **M21**             50,269,416      885,941                                                                                                        128,120                  905,385                                                         52,188,862
  **M22**             162,025,962     861,129                                                                                                                                                                                                 162,887,091
  **M23**             29,484,814                                                                                                                                                                                                              29,484,814
  **M24**             180,532,696     352,905                                                                                                        685,128                                                         1,649,227                184,835,243
  **M25**             896,803,169     4,472,844                                                                 29,155,815                           486,612                  21,253,177    297,909,967                                       1,250,081,584
  **M26**             48,856,108      1,376,742                                                                                                                                                                      598,621                  50,831,471
  **M27**             790,013,598                                                                                                                                             2,541,940     18,180,494                                        810,736,032
  **M28**             92,475,813                                                                                                                                              1,666,710     1,426,867                                         95,569,390
  **M29**             646,804,735     459,452                                                                                                        313,543                  12,256,309    1,839,703                                         661,673,742
  **M30**             24,183,728                                                                                                                                                                                                              24,183,728
  **M31**             324,786,331                                                                                                                                             5,151,046                                                       329,937,377
  **M32**             390,217,566                                                                                                                                             818,492                                                         391,036,058
  **M33**             46,223,582                                                                                                                                                                                                              46,223,582
  **M34**             125,631,723                                                                  2,735,164                                                                  1,822,325     1,674,281                                         131,863,493
  **M35**             488,223,880                                                                  1,363,338                                                                  8,760,094     4,522,744                                         502,870,056
  **M36**             33,006,739                                                                                                                                                                                                              33,006,739
  **M37**             23,418,337                                                                                                                                                                                                              23,418,337
  **M38**             46,101,388                                                                                                                                                                                                              46,101,388
  **M39**             27,487,975                                                                                                                                                                                                              27,487,975
  **M40**             20,088,773                                                                                                                                                                                                              20,088,773
  **M41**             27,408,608                                                                                                                                                                                                              27,408,608
  **M42**             12,435,301                                                                                                                                                                                                              12,435,301
  **M43**             77,259,589                                                                                                                                                                                                              77,259,589
  **M44**             284,733,513                                                                                                                                                                                                             284,733,513
  **M45**             44,372,830                                                                                                                                                                                                              44,372,830
  **M46**             89,188,731                                                                                                                                                                                                              89,188,731
  **M47**             108,520,771                                                                                                                                                                                                             108,520,771
  **M48**             30986,855                                                                                                                                                                                                               30,986,855
  **M49**             34,753,952                                                                                                                                                                                                              34,753,952
  **M50**             53,158,418                                                                                                                                                                                                              53,158,418
  **M51**                                                                                                                                            15,908,470                                                                               15,908,470
  **M52**                                                                                          30,236,800                                        43,804,798                                                      2,369,281                76,410,879
  **M53**             463,948,611                                                                                                                                                                                                             463,948,611
  **M54**             21,448,937                                                                                                                                                                                                              21,448,937
  **M55**             79,454,258                                                                                                                                                                                                              79,454,258
  **M56**             79,252,367                                                                                                                                                                                                              79,252,367
  **M57**             39,700,636                                                                                                                                                                                                              39,700,636
  **M58**             86,848,220                                                                                                                                                                                                              86,848,220
  **M59**             17,421,558                                                                                                                                                                                                              17,421,558
  **M60**             21,097,294                                                                                                                                                                                                              21,097,294
  **M61**             88,863,196                                                                                                                                                                                                              88,863,196
  **M62**             38,437,245                                                                                                                                                                                                              38,437,245
  **M63**             102,677,796                                                                                                                                                                                                             102,677,796
  **M64**             35,880,113                                                                                                                                                                                                              35,880,113
  **M65**             23,867,787                                                                                                                                                            1,449,639                                         25,317,426
  **M66**             13,548,270                                                                                                                                                                                                              13,548,270
  **M67**             5,583,766                                                                                                                                                                                                               5,583,766
  **M68**             5,640,311                                                                                                                                                                                                               5,640,311
  **M69**             9,156,984                                                                                                                                                                                                               9,156,984
  **M70**             10,312,539                                                                                                                                                                                                              10,312,539
  **M71**             13,648,742                                                                                                                                                                                                              13,648,742
  **M72**             4,644,757                                                                                                                                                                                                               4,644,757
  **M73**             54,507,901                                                                                                                                                                                                              54,507,901
  **M74**             77,998,658                                                                                                                                                                                                              77,998,658
  **M75**             39,341,209                                                                                                                                                                                                              39,341,209
  **M76**             12,303,039                                                                                                                                                                                                              12,303,039
  **M77**             7,437,147                                                                                                                                                                                                               7,437,147
  **M78**             30,479,610                                                                                                                                                                                                              30,479,610
  **M79**             45,861,423                                                                                                                                                                                                              45,861,423
  **M80**             18,882,764                                                                                                                                                                                                              18,882,764
  **M81**             285,519,682                                                                                                                                                           1,729,889                                         287,249,571
  **M82**             19,376,253                                                                                                                                                                                                              19,376,253
  **M83**             36,030,998                                                                                                                                                                                     26,693,032               62,724,030
  **M84**             14,114,954                                                                                                                                                                                                              14,114,954
  **M85**             30,984,346                                                                                                                     27,085,013                                                                               58,069,359
  **M86**             50,436,190                                                                                                                                                                                                              50,436,190
  **TPA ^2^**         7,540,531,449   125,100,073             1,699,331   4,148,293                50,488,315   37,920,485               1,620,283   115,671,871              147,536,576   449,779,867              53,283,701   0           8,527,780,244
  **Sum ^3^**         83              19                      2           2                        7            7                        3           13                       21            19                       14           0           
  **Peak Area (A)**   **A ≥ 10^9^**   **10^9^ \>A ≥ 10^8^**               **10^8^ \> A ≥ 10^7^**                **10^7^ \> A ≥ 10^6^**               **10^6^ \> A ≥ 10^5^**                 **10^4^ ≤ A \< 10^5^**                **A = 0**   
  **Color**                                                                                                                                                                                                                                   

^1^ These data are comparable. ^2^ Total peak areas. ^3^ The total number of metabolites detected.

3. Discussion {#sec3-molecules-21-00176}
=============

The metabolism of siamenoside I in rats was firstly investigated in the present work. In total, 86 new metabolites of siamenoside I were detected in different biological samples from rats, and nine of them were unambiguously identified by comparison with reference compounds, and the others were tentatively identified by careful interpretation of their LC-MS^n^ data.

3.1. The Metabolic Pathways of Siamenoside I in Rats {#sec3dot1-molecules-21-00176}
----------------------------------------------------

Based on the structures of the metabolites (**M1**--**M86**), the metabolic pathways of siamenoside I in rats are proposed and shown in [Figure 1](#molecules-21-00176-f001){ref-type="fig"}. From [Figure 1](#molecules-21-00176-f001){ref-type="fig"}, we can find that the metabolic reactions of siamenoside I include deglycosylation, hydroxylation, dehydrogenation, deoxygenation, isomerization, and glycosylation.

Most of the metabolic reactions of siamenoside I are the same to mogroside V \[[@B10-molecules-21-00176]\]. However, there are also some differences. For example, methylation metabolites were not found in the metabolism of siamenoside I, and deoxygenation is found to be a novel metabolic reaction of mogrosides. Furthermore, pentahydroxylation, didehydrogenation are also found as novel metabolic reactions of mogrosides.

Among 86 metabolites, 63 metabolites (**M6**, **M13**, **M20**, **M21**, **M26**, **M27**, **M30**--**M86**) are formed by oxidation reactions such as hydroxylation and dehydrogenation, and 79 metabolites (**M8**--**M86**) are formed by deglycosylation, which indicate that deglycosylation and oxidation (hydroxylation, dehydrogenation) are the major metabolic reactions of siamenoside I.

Astonishingly, four metabolites (**M7**, **M14**, **M22**, and **M23**) are formed by reduction reaction (deoxygenation). The deoxygenation reaction might occur in hexose, not in aglycone, which is inferred from the identification of **M22** ([Section 2.2.10](#sec2dot2dot10-molecules-21-00176){ref-type="sec"}.).

Furthermore, 23 metabolites (**M6**, **M7**, **M13**, **M14**, **M22**, **M23**, **M26**-**M28**, **M30**, **M62**-**M65**, **M78**--**M86**) are firstly reported as new metabolites of mogrosides.

These results suggest that siamenoside I has its own metabolism characteristics in comparison with mogroside V.

3.2. Distribution of the Metabolites of Siamenoside I in Rats {#sec3dot2-molecules-21-00176}
-------------------------------------------------------------

From [Table 2](#molecules-21-00176-t002){ref-type="table"}, we could find that total peak areas of all detected compounds (siamenoside I and metabolites) in different rat organs are ranked as follows: intestines (449,779,867) \> stomach (147,536,576) \> kidneys (115,671,871) \> brain (53,283,701) \> liver (50,488,315) \> spleen (37,920,485) \> heart (4,148,293) \> lungs (1,620,283). In addition, the total numbers of compounds (siamenoside I and metabolites) detected in different organs are in the order of stomach (22) \> intestines (20) \> brain (15) \> kidneys (14) \> liver (7) \> spleen (7) \> lungs (4) \> heart (2). Therefore, siamenoside I and its metabolites are mainly distributed to the intestines, stomach, kidneys, and brain.

We also could find the specific metabolites detected in different biosamples. For example, 50 metabolites (**M10**-**M12**, **M16**, **M23**, **M30**, **M33**, **M36**--**M50**, **M53**-**M64**, **M66**--**M80**, **M82**, **M84**, **M86**) are only detected in feces; **M2** is only detected in urine and the brain; **M7** is only detected in urine and feces; **M51** is only detected in kidneys; **M85** is only detected in kidneys and feces; **M17**, **M31**, **M32** are only detected in stomach and feces; **M65** and **M81** are only detected in intestines and feces; **M83** is only detected in brain and feces. Besides, siamenoside I and 14 metabolites (**M1**--**M6**, **M9**, **M13**, **M18**--**M19**, **M24**, **M26**, **M52**, **M83**) are detected in the brain for the first time.

**M9** (mogroside IIIE) is detected in all biosamples except muscle, indicating that it is the most widely distributed metabolite.

3.3. The Proposed in Vivo Process of Siamenoside I in Rats {#sec3dot3-molecules-21-00176}
----------------------------------------------------------

From [Table 2](#molecules-21-00176-t002){ref-type="table"}, we could find that **M1**--**M29** seem to be the main metabolites, and most of the other metabolites are only detected in feces. We think the reasons for this result may be: (1) the first pass effect of these metabolites may be very high, *i.e.*, their hepatic extraction ratios are very high, which leads to their very low contents in plasma, organs, and urine samples. As a result, they are not easily detected in these samples; (2) these metabolites are mainly excreted into bile and then to feces, which make their contents in feces high and detectable.

Based on our research results and general metabolic knowledge, we hypothesize that the *in vivo* process of siamenoside I in rats may be as follows.

After oral administration, siamenoside I is degraded into its secondary glycosides (e.g., mogroside III, IIIE, IIIA1, IIE, IIA~2~, IA~1~, IE~1~, *etc.*) and its aglycone (mogrol) or dehydrogenated aglycone (dehydrogenated mogrol) by gastric juice, intestinal juice, intestinal enzymes, or intestinal microflora. Then, mogrol or dehydrogenated mogrol permeate across intestinal mucosa and enter the liver, where they undergo extensive oxidative metabolic reactions to form lots of hydroxylation and/or dehydrogenation metabolites. These polar oxidative metabolites may be largely excreted into the bile and then to the feces, and only a limited amount of them enter general circulation. Besides, some of them may also undergo hepatoenteral circulation and are absorbed into general circulation, and then distributed to different organs, and finally excreted into feces or/and urine.

3.4. Bioactivities of the Metabolites of Siamenoside I {#sec3dot4-molecules-21-00176}
------------------------------------------------------

On the basis of literature retrieval, eight metabolites (**M3**, mogroside IVA; **M4**, mogroside IVE; **M8**, mogroside III; **M15**, mogroside IIE; **M24**, mogroside IA~1~; **M25**, mogroside IE~1~; **M29**, mogrol; **M9**, mogroside IIIE) of siamenoside I can be regarded as bioactive metabolites.

Among them, seven metabolites (**M3**, **M4**, **M8**, **M15**, **M24**, **M25**, **M29**) are able to inhibit the induction of Epstein-Barr virus early antigen by 12-*O*-tetradecanoylphorbol-13-acetate in Raji cells \[[@B5-molecules-21-00176]\]. **M4** and **M9** can inhibit maltase \[[@B7-molecules-21-00176]\]. Hence, they might contribute to the bioactivities of siamenoside I.

4. Materials and Methods {#sec4-molecules-21-00176}
========================

4.1. Chemicals and Reagents {#sec4dot1-molecules-21-00176}
---------------------------

Siamenoside I, mogroside III, mogroside IIIE, mogroside IVE, mogroside V, mogroside IIE, 11-oxomogroside IIE, and mogrol (all purities \>98%, determined by HPLC-DAD-ELSD) were isolated from the dried fruits of *Siraitia grosvenorii* and the 50% mogroside V enzymatic hydrolysate by the authors \[[@B12-molecules-21-00176],[@B13-molecules-21-00176]\], and their structures were confirmed by spectral data (UV, IR, NMR and MS). Mogroside IVA, mogroside IIIA~1~ and mogroside IIA~2~ (all purities \>98%, determined by HPLC-DAD-ELSD) were purchased from Chengdu MUST Bio-technology Co., Ltd. (Chengdu, Sichuan, China).

Ultra-pure water was prepared by a Millipore Milli-Q Integral 3 Ultrapure Water System (Billerica, MA, USA). Acetonitrile (HPLC grade) was bought from Fisher Chemicals Co. (Fairlawn, NJ, USA) and formic acid (HPLC grade) was purchased from Mreda Technology Inc. (Beijing, China).

4.2. Animals {#sec4dot2-molecules-21-00176}
------------

Sprague-Dawley (SD) rats (male, 210 ± 20 g) were bought from the Experimental Animal Center of Peking University Health Science Center (Beijing, China). They were handled in agreement with the Guide for the Care and Use of Laboratory Animals of the US National Institutes of Health. All animal experiments were approved by the Biomedical Ethical Committee of Peking University (Approval No. LA2011-058).

4.3. Instruments {#sec4dot3-molecules-21-00176}
----------------

A Shimadzu LCMS-IT-TOF instrument was used to perform HPLC-ESI-IT-TOF-MS^n^ analysis, which consists of a CBM-20A system controller, a DGU-20A~3~ degasser, two LC-20AD pumps, an SIL-20AC autosampler, a CTO-20A column oven, an SPD-M20A photodiode array (PDA) detector, an ESI ion source, and a hybrid IT-TOF mass spectrometer (Shimadzu, Kyoto, Japan).

4.4. Animal Experiments and Sample Collection {#sec4dot4-molecules-21-00176}
---------------------------------------------

Eight rats were divided into two groups: two were blank group and the others were test group. Each rat was put into a clean metabolic cage (Suzhou Fengshi Laboratory Animal Equipment Co., Suzhou, Jiangsu, China) and given food and water *ad libitum*.

Because the research aim is to find the general/average differences between test group rats (drug-containing sample) and blank group rats (blank sample), the individual differences among the same group rats are not taken into consideration. Accordingly, all of the biosamples from each group were combined into one sample which was more representative than individual samples in the following sample collection processes.

The animal experiment lasted six days. The whole urine and feces of days 1--2 were collected as blank urine and feces samples, respectively. On days 3--5, the rats of test group were orally administrated with siamenoside I \[50 mg/kg body weight, in normal saline (NS) solution\] at 9:00, and all 72-h urine and feces were collected as drug-containing urine and feces samples, respectively. The rats of blank group were orally administrated with the same volume of NS. On day 6 at 9:00, the test and the blank group were treated with siamenoside I and NS again, respectively. After 1 h, blood sample was collected into a vacuum tube with sodium citrate as anticoagulant (Hebei Xinle Technology Co., Ltd., Shijiazhuang, Hebei, China) from rat heart under anesthesia. Then, the organs (heart, liver, spleen, lung, kidneys, stomach, small intestine, brain) and skeletal muscles of rats were collected and washed with NS, separately. All samples were kept at −80 °C before further pretreatment.

4.5. Sample Preparation {#sec4dot5-molecules-21-00176}
-----------------------

### 4.5.1. Blood Samples {#sec4dot5dot1-molecules-21-00176}

The blood samples were centrifuged at 3000 rpm for 20 min at 4 °C, and the supernatant plasma samples were collected. Afterward, 8 mL methanol was added to 2 mL of plasma sample, and then was mixed and centrifuged at 9000 rpm for 30 min. The supernatant was collected and evaporated to dryness at 55 °C by a rotatory evaporator. The 15 mg residue was reconstituted in 1.00 mL methanol, filtrated through 0.45 μm filter membrane, and stored at 4 °C before analysis.

### 4.5.2. Urine Samples {#sec4dot5dot2-molecules-21-00176}

Urine samples were filtered and then evaporated to dryness under vacuum at 55 °C by a rotatory evaporator. Subsequently, the residue was ultrasonically extracted with 10 mL methanol for 30 min, and the extract was then centrifuged at 9000 rpm for 30 min. The supernatant was transferred to another tube and evaporated to dryness at 55 °C by a rotatory evaporator. Next, a 100 mg residue was dissolved in 1.00 mL methanol, filtered through 0.45 μm membranes, and stored at 4 °C before analysis.

### 4.5.3. Feces Samples {#sec4dot5dot3-molecules-21-00176}

Feces samples were dried at 55 °C and pulverized. Subsequently, the 10 g powder was ultrasonically extracted with 50 mL methanol for 30 min for three times, and the three supernatants were combined and evaporated to dryness. Next, the residue was mixed with 20 mL methanol and centrifuged at 9000 rpm for 30 min. The supernatant was evaporated to dryness again at 55 °C and the residue was collected. Then, 15 mg of residue was dissolved in 1.00 mL methanol, 0.45 μm membranes, and stored at 4 °C before analysis.

### 4.5.4. Organ and Skeletal Muscle Samples {#sec4dot5dot4-molecules-21-00176}

Each organ was weighed, minced, and homogenized in 4 times volume (mL/g) of 4 °C NS by a homogenizer (Ultra-Turrax T8, Ika-Werke, Gmbh & Co. KG, Staufen, Germany). Then, 10 mL homogenate was mixed with 9 times volume (mL/mL) of acetonitrile, ultrasonically treated for 30 min, and centrifuged at 12,000 rpm for 30 min at 4 °C. Afterward, the supernatant was collected and evaporated to dryness at 50 °C. The residue was dissolved in 1.00 mL methanol, filtered through 0.45 μm filter membrane, and stored at 4 °C before analysis. The skeletal muscle samples were treated by the same method.

4.6. LC-MS^n^ Conditions {#sec4dot6-molecules-21-00176}
------------------------

The column used was Inertsil ODS-3 C~18~ (250 mm × 4.6 mm, 5 μm) (Shimadzu, Kotyo, Japan) protected with a Phenomenex Security Guard column (C~18~, 4 mm × 3.0 mm, 5.0 μm) (Phenomenex, Torrance, CA). The column temperature was 35 °C. The injection volume of all samples was 20 μL. The mobile phases were water-formic acid (100:0.1, *v*/*v*) (A) and acetonitrile (B).The flow rate was 1.0000 mL/min. A gradient elution program was used: 0.01--10.00 min, 10%--18% B; 10.00--20.00 min, 18%--28% B; 20.00--35.00 min, 28%--45% B; 35.00--60.00 min, 45%--90% B; 60.00--70.00 min, 90%--100% B; 70.00--80.00 min, 100% B. The UV spectrum was recorded from 195 nm to 400 nm.

The parameters of the ESI-IT-TOF-MS^n^ instrument were: (1) flow rate: 0.2000 mL/min (split from HPLC effluent); (2) positive ion (PI) and negative ion (NI) alternate detection; (3) mass range: MS, *m*/*z* 300--2000; MS^2^ and MS^3^, *m*/*z* 50--2000; (4) temperature of heat block and curved desolvation line (CDL): 250 °C; (5) nebulizing nitrogen gas flow: 1.5 L/min; interface voltage: (+), 4.5 kV; (−), −3.5 kV; detector voltage: 1.70 kV; (6) ion accumulation time: MS, 30 ms; MS^2^ and MS^3^, 20 ms; relative collision-induced dissociation (CID) energy: 50%; (7) data-dependent MS^2^ and MS^3^ fragmentation; (8) All data were recorded and analyzed by LCMS solution Version 3.60, Formula Predictor Version 1.01, and Accurate Mass Calculator (Shimadzu, Kyoto, Japan). The mass range of 50--3000 Da was calibrated by a trifluoroacetic acid sodium solution (2.5 mM).

4.7. Strategy for Profiling and Identification of the Metabolites of Siamenoside I in Biosamples {#sec4dot7-molecules-21-00176}
------------------------------------------------------------------------------------------------

The strategy \[[@B14-molecules-21-00176]\] previously proposed by the authors was used to find and identify the metabolites of siamenoside I in the present study. In short, the base peak chromatograms (BPCs) of drug-containing samples and blank samples were thoroughly analyzed and compared. Meanwhile, the possible metabolites predicted by general metabolism rules were also screened and confirmed by comparing their corresponding extracted ion chromatograms (EICs). The metabolites were identified by comparison of their retention times and MS^n^ data with those of reference compounds, or tentatively identified by interpretation of their MS^n^ data.

4.8. Preliminary Evaluation of the Relative Contents of Siamenoside I and Its Metabolites in Biosamples {#sec4dot8-molecules-21-00176}
-------------------------------------------------------------------------------------------------------

To preliminarily estimate the relative contents of siamenoside I and its metabolites in biosamples, the peak area of each metabolite calculated from its NI EIC was used. In the present study, only the data of different organ samples were comparable, since they were prepared and analyzed by the same method.

5. Conclusions {#sec5-molecules-21-00176}
==============

The metabolism of siamenoside I in rats was studied for the first time. In total, 86 new metabolites were detected. Nine of them were unambiguously identified by comparison with reference compounds, and the other 77 were tentatively identified by HPLC-ESI-IT-TOF-MS^n^ technique. The metabolic pathways of siamenoside I in rats were proposed based on the structures of metabolites. The metabolic reactions of siamenoside I were found to be deglycosylation, hydroxylation, dehydrogenation, deoxygenation, isomerization, and glycosylation, among which deoxygenation, pentahydroxylation, and didehydrogenation were novel metabolic reactions of mogrosides. In addition, 23 metabolites were new metabolites of mogrosides. The distributions of siamenoside I and its 86 metabolites in rat organs were firstly reported, and they were mainly distributed to intestines, the stomach, kidneys, and the brain. Mogroside IIIE was the most widely distributed metabolite. Eight metabolites had bioactivities, indicating that they might contribute to the bioactivities of siamenoside I. These findings not only provide valuable information on the metabolism and disposition of siamenoside I and mogrosides in rats but also provide useful information on the chemical basis of the pharmacological effects of siamenoside I and mogrosides *in vivo*.
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